Sign In
Get Clay Free →

Suggestions

    Christopher Winrow

    Chief Scientific Officer at Lucy Therapeutics

    Christopher Winrow is a seasoned Cross-Functional Drug Discovery and Development Program and Team Leader with over 20 years of experience spanning biotech startups to global pharma companies.

    He has a strong track record in executing target identification, validation, and overseeing Phase 1 through Phase 3 clinical studies leading to regulatory approval.

    Christopher Winrow led the successful discovery and regulatory approval process of Belsomra® (suvorexant), a first-in-class CNS therapeutic, within a span of less than 10 years, obtaining approvals from various U.S. and international regulatory agencies.

    His expertise includes integrating translational biomarkers in nonclinical and clinical studies, scientific leadership for post-launch activities, and involvement in commercial development.

    With a focus on portfolio strategy, pipeline prioritization, and resource deployment, Christopher Winrow has experience in building, leading teams, and mentoring within internal and external organizations.

    He possesses Business Development acumen demonstrated through collaborations, due diligence, and engagement with investors and analysts, in addition to being involved in company strategy and corporate communications.

    As a Neuroscience expert, Christopher Winrow has chaired advisory board meetings, facilitated medical education initiatives, and provided scientific strategy for product launch planning and execution.

    His vast publication record includes over 70 peer-reviewed articles, 150 presentations, and multiple patent filings, along with contributions to IND, NDA, and international regulatory submissions.

    Christopher Winrow holds a Ph.D. in Cell Biology from the University of Alberta and a B.Sc. in Molecular Biology from McMaster University.

    Throughout his career, he has held key positions including Chief Scientific Officer at Lucy Therapeutics, Vice President and Head of Translational Medicine at Cyclerion, and various roles at Merck & Co., Inc., Ironwood Pharmaceuticals, and the Salk Institute for Biological Studies.

    Christopher Winrow
    Get intro to Christopher
    Add to my network

    Location

    Cambridge, Massachusetts, United States
    Location